Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Opinion in Oncology|May 18, 1999
Taxanes as radiosensitizers for head and neck cancerL L Herscher, J Cook
Oncology (Williston Park, N.Y.)|November 7, 1999
Principles of chemoradiation: theoretical and practical considerationsL L Herscher, J A Cook, R Pacelli, et al.
American Journal of Clinical Pathology|February 1, 1984
Distribution of LDH-1 in normal, ischemic, and necrotic myocardium. An immunoperoxidase studyL L Herscher, R J Siegel, J W Said, et al.
Human Pathology|August 1, 1984
Myocytolysis (vacuolar degeneration) of myocardium: immunohistochemical evidence of viabilityG M Edwalds, J W Said, M I Block, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Phase I study of paclitaxel as a radiation sensitizer in the treatment of mesothelioma and non-small-cell lung cancerL L Herscher, S M Hahn, G Kroog, et al.
International Journal of Radiation Oncology, Biology, Physics|November 15, 1994
Protection against SR 4233 (Tirapazamine) aerobic cytotoxicity by the metal chelators desferrioxamine and tironL L Herscher, M C Krishna, J A Cook, et al.
International Journal of Radiation Oncology, Biology, Physics|October 15, 1994
National Cancer Institute (phase II) study of high-grade glioma treated with accelerated hyperfractionated radiation and iododeoxyuridine: results in anaplastic astrocytomaF J Sullivan, L L Herscher, J A Cook, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999
Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancerZ Chen, P S Malhotra, G R Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Concurrent paclitaxel and radiation in the treatment of locally advanced head and neck cancerJ B Sunwoo, L L Herscher, G S Kroog, et al.
Pageof 1